Arasani, Sahabi -.
HRN: 12-65-99 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/27/2022
MEBENDAZOLE 100MG/5ML, 60ML SUSPENSION
12/27/2022
01/03/2023
ORAL
5ml
OD
T/c Ascariasis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes